The company provides retail foreign exchange services, including currency notes, multi-currency travel cards, and cross-border money transfer services for travelers, students, and corporate clients.
The company lacks a durable moat as evidenced by a massive revenue CAGR of -32.9% and declining margins. While it holds regulatory licenses for forex and remittances, these do not provide pricing power in a highly commoditized and increasingly digital market.
Capital has been primarily directed toward inter-corporate deposits to group entities rather than productive reinvestment or shareholder returns. The lack of dividends despite profitability suggests a priority on supporting the parent group's liquidity.
The investment collapsed as the inter-corporate deposits to distressed group entities became unrecoverable, effectively draining the company's liquid assets to subsidize a bankrupt parent. As the physical branch network was dismantled, the business failed to pivot to digital channels, leading to a total loss of market share in a commoditized forex market. The combination of regulatory penalties for FEMA violations and the financial contagion from Ebix Inc.'s Chapter 11 filing eventually rendered the remaining shell of the company untradeable and worthless to minority shareholders.
RichFakir rates Delphi World Money Ltd's business quality as poor — 27/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Delphi World Money Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Delphi World Money Ltd is: Not rated. A poor business at an expensive price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Delphi World Money Ltd's fair value is about ₹3 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →